Product Information
VALSARTAN 40 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0973 per EA under NDC 31722015130. Its NADAC has been published 256 times since Sep 29, 2021.
FDA first approved this application on Jan 5, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Valsartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722015130
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203311FDA Approved
1/5/2015
TE Code
AB
On Market Since
6/23/2021
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN 40 MG TABLET has been published 256 times since Sep 29, 2021, and over the history we have for it it has declined 63.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0973 per EA |
|---|---|
| All-time high | $0.2643 (Oct 13, 2021) |
| All-time low | $0.0960 (Jul 22, 2026) |
| 52-week high | $0.1286 |
| 52-week low | $0.0960 |
| Median price | $0.1381 |
| Average price | $0.1489 |
| Largest weekly change | +45.1% (Aug 21, 2024) |
| Weeks tracked | 256 |
| Tracking since | Sep 29, 2021 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VALSARTAN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN 40 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0973 per EA (NDC 31722015130), effective Aug 19, 2026.
How has the price of VALSARTAN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALSARTAN 40 MG TABLET has declined 63.2%. It has been tracked across 256 weekly CMS publications since Sep 29, 2021.
What are the highest and lowest recorded NADAC prices for VALSARTAN 40 MG TABLET?
Since Sep 29, 2021, the NADAC for VALSARTAN 40 MG TABLET has ranged from a low of $0.0960 (Jul 22, 2026) to a high of $0.2643 (Oct 13, 2021), with a median of $0.1381 per EA.
Are there cheaper alternatives to VALSARTAN 40 MG TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VALSARTAN 40 MG TABLET?
VALSARTAN 40 MG TABLET (NDC 31722015130) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.